Journal: Frontiers in Cell and Developmental Biology
Article Title: Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
doi: 10.3389/fcell.2022.945007
Figure Lengend Snippet: Growth suppression of MPM cells on MeT-5A cells by 9D2 and 3E1 (A) MESO-14 and NCI-H2052 cell sheets were labeled with DiI (red) and were cocultured on a MeT-5A cell monolayer in the presence of control IgY (1.0 μg/ml; left), 9D2 (1.0 μg/ml; middle), or 9D2 and 3E1 (1.0 μg/ml each; right). Cell sheets were observed through a fluorescence microscope at the time of antibody addition (0 d) and after 2 days (2 d) (B) MESO-1, MESO-1-CADM1, NCI-H28, NCI-H2052, and MESO-14 cell lines were cocultured on a MeT-5A cell monolayer in the presence of either control IgY (1.0 μg/ml) or 9D2 (1.0 μg/ml) (upper graph), and in the presence of either control IgY (2.0 μg/ml) or 9D2 and 3E1 (1.0 μg/ml each) (lower graph). For individual cell sheets, the ratio of the cell number at the time of antibody addition (0 d) to that after 2 days (2 d) was calculated, and plotted as the growth rate in a dot graph. The mean was calculated from the ratios of five to ten sheets for each coculture group, and is shown below or above the dots. p -values are shown at the top of each graph. Bar = 100 μm (C) TUNEL assays of MESO-14 and NCI-H2052 cells cocultured on a MeT-5A cell monolayer for 2 days in the presence of either control IgY or 9D2 and 3E1. The mean proportion of TUNEL-positive MPM cells (%) is plotted with a thin line indicating the standard deviation. A p -value between two groups is shown at the top of each graph.
Article Snippet: A control chicken IgY was purchased from R&D Systems (Minneapolis, MN, United States), and a normal human IgG from Fujifilm Wako Chemicals (Osaka, Japan).
Techniques: Labeling, Fluorescence, Microscopy, TUNEL Assay, Standard Deviation